TNXP icon

Tonix Pharmaceuticals
TNXP

Overview Fund Trends Analyst Outlook Journalist POV

23 hedge funds and large institutions have $11.1M invested in Tonix Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

more ownership

Funds ownership: →

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

57% less capital invested

Capital invested by funds: $25.7M → $11.1M (-$14.6M)

Holders
23
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$5.05M
2
+$1.37M
3
+$712K
4
Vanguard Group
Vanguard Group
Pennsylvania
+$250K
5
Millennium Management
Millennium Management
New York
+$222K

Top Sellers

1
-$1.18M
2
-$1.15M
3
-$375K
4
Nuveen Asset Management
Nuveen Asset Management
Illinois
-$315K
5
Bank of New York Mellon
Bank of New York Mellon
New York
-$305K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$11K
27
$10K
28
$4K
29
$3K
30
$2K
31
$2K
32
$2K
33
$2K
34
$1K
35
$1K
36
$1K
37
$250
38
–
39
–
40
–
41
–
42
–
43
–
44
–
45
–
46
–
47
–
48
–
49
–
50
–
1
2
3 4